Glenmark Pharmaceuticals announced that India Ratings and Research (Ind-Ra) has upgraded the company's long-term bank loans to ‘IND AA+' from ‘IND AA' with a Stable Outlook, while affirming the short-term bank loans at ‘IND A1+'.